During a recent hearing in Washington, members of Congress were alerted to the presence of DNA fragments in the Pfizer-BioNTech COVID-19 vaccine.
Dr. Robert Malone, a key figure in the development of messenger RNA (mRNA) technology used in the vaccine, testified about the inclusion of a DNA sequence called Simian Virus 40 (SV40), which had not been disclosed to certain regulators. Dr. Malone emphasized the genotoxicity risk associated with the residual DNA, suggesting a potential link to the unusual types of cancers emerging post-vaccination.
Expressing concern about the impact on unborn children, Dr. Kimberly Biss, an obstetrician-gynecologist, highlighted the rising rates of miscarriages among her patients. Dr. Malone argued that the vaccine’s inclusion of the SV40 sequence renders it adulterated and called for its recall by the U.S. Food and Drug Administration (FDA). However, the FDA asserted that no safety concerns related to the sequence or residual DNA amount have been identified, dismissing the need for a recall.
Questions surround whether the FDA conducted relevant testing to support its position, as it declined to provide details about when it learned of the sequence and from whom. Both Health Canada and the European Medicines Agency reported that Pfizer and BioNTech did not disclose the SV40 sequence in their submissions.
Dr. Malone highlighted the absence of rigorous genotoxicity and insertional mutagenesis assays performed by the FDA or the vaccine companies, questioning the basis for the FDA’s stance. Pfizer and BioNTech have yet to respond to requests for comment on these concerns.
Dr. Malone drew attention to a Moderna patent that acknowledged potential problems, including insertional mutagenesis, associated with directly injecting DNA into living hosts. Independent testing by scientists, including Phillip Buckhaults, revealed the presence of the DNA fragments in the vaccine, raising concerns about the risk of insertional mutagenesis.
During the hearing, lawmakers expressed various concerns. Rep. Warren Davidson emphasized the distress of constituents compelled to get vaccinated for employment, questioning whether the vaccine leaves a persistent marker. Dr. Malone noted the extended presence of modified mRNA in the body, highlighting the lack of precise information on the duration due to limited regulatory testing.
Rep. Matt Gaetz voiced concerns about vaccine injuries and the challenge of attributing them to issues like blood clots. Rep. Thomas Massie lamented the departure of FDA officials Marion Gruber and Dr. Philip Krause over rushed vaccine approval, suggesting that a politically driven process compromised scientific rigor.
Rep. Marjorie Taylor Greene concluded the hearing by advocating for accountability and transparency in vaccine-related matters. She pledged to conduct additional hearings, noting growing support among colleagues for addressing concerns surrounding the COVID-19 vaccines.